We have used a superparamagnetic microbead selection system to positively select a murine bone marrow CD8 + cell population. The functional ability of these cells to enhance allogeneic bone marrow engraftment was compared with that of fluorescence activated cell sorter purified CD8
Transplantation of bone marrow has become an effective mode of treatment for patients with various leukemias, aplastic anemia, solid tumors and other metabolic disorders. [1] [2] [3] The development of animal models in which lethally irradiated mice are infused with syngeneic or allogeneic bone marrow cells has provided considerable insight into the complexity of the histocompatability system. 4 Following the discovery and characterization of hematopoietic stem cells, the murine model has been particularly useful for studying the kinetics of engraftment and the long-term repopulation potential of stem cells after lethal irradiation. 5 Since the inception of the murine bone marrow transplantation model, it has become quite clear that the incidence and severity of graft-versus-host disease (GVHD) correlates with T cells present in the bone marrow inoculum. [6] [7] [8] [9] On the other hand, complete removal of T cells from the bone marrow inoculum has resulted in significant increase in graft failure. 10 The incidence of GVHD, however, was reduced drastically, in the latter instance, indicating that T cells are directly responsible for the induction of GVHD.
Sachs and colleagues 11 developed the allogeneic chimera model (A+B → B) where T cell-depleted bone marrow was used as a source of stem cells. In this particular model, when equal numbers of syngeneic and allogeneic bone marrow cells were injected into lethally irradiated recipients, a small percentage of allogeneic cells was found to be persistently present in the chimeras indicating durable allogeneic engraftment. These chimeras remain tolerant to both host and donor allografts while remaining immunocompetent as demonstrated by their ability to reject a third party skin graft. 12 Increasing the dose of T cell-depleted allogeneic bone marrow three-fold resulted in an increase of mean allogeneic engraftment to about 50%. However, when the allogeneic marrow was not T cell-depleted, the percentage of allogeneic chimerism increased to 90-100%, suggesting that the T cells may be responsible for facilitating bone marrow engraftment. 12 It has been suggested that T cells can enhance stem cell engraftment via two different, though not mutually exclusive, routes. One theory is that many interleukins produced by T cells help sustain the proliferation and differentiation of stem cells in an irradiated host. Secondly, it is known that donor T cells can elicit effector functions such as cytotoxicity or suppressor activity. In two independent series of experiments, Lapidot et al 13 and Martin 14 have shown that CD8 + cells obtained from lymph nodes and from the thymus, respectively, added to T cell-depleted bone marrow inocula can prevent allogeneic marrow graft rejection in the murine irradiation chimera model. From the phenotypic description of this cell type, it appears that the facilitation of engraftment is due to the presence of a mature T cell subset in the bone marrow inoculum. In fact, Martin 14 has shown that lymph node CD8 + T cells are very effective in preventing bone marrow rejection. Recently, Kaufman et al 15 have described a CD8 + , CD3 + , TCR Ϫ cell subset in murine bone marrow as the facilitating cells in allogeneic stem cell engraftment. Taken together, these studies strongly suggest that CD8
+ cells play an important role in the engraftment of allogeneic bone marrow.
In the present study, we have used alternative methods to isolate CD8 + cells from murine bone marrow to determine their efficacy in promoting allogeneic bone marrow cell engraftment. Using the murine model developed by Sachs and colleagues, 11 we demonstrate that CD8 + , but not CD4 + , T cells from bone marrow promote allogeneic engraftment without inducing GVHD. CD8
+ cells enriched through positive selection by immunomagnetic cell iso-lation were found to be as efficient as FACS-purified CD8 + cells in promoting T cell-depleted allogeneic bone marrow engraftment in lethally irradiated mice. Paramagnetic microbead enrichment of the bone marrow cells gave approximately 20-to 30-fold enrichment of CD8 + cell population. CD8
+ cell-enriched marrow preparations were very effective in facilitating allogeneic engraftment, whereas bone marrow depleted of CD8 + cells by this method exhibited little, if any, activity. Finally, our data indicate that the facilitating activity of the CD8 + cells we obtained, either by immunomagnetic enrichment or by flow cytometric cell sorting, segregates with cells almost exclusively positive for surface expression of CD3 and TCR marker antigens.
Materials and methods

Mice
Six-to eight-week-old, female, C57BL/10SnJ (B10) and B10.BR/SgSn (B10.BR) mice were purchased from the Jackson Laboratories (Bar Harbor, ME, USA). These mice were housed in a specific pathogen-free facility at the Stanford Research Institute International, Menlo Park, CA, USA.
Monoclonal antibodies and other reagents
Monoclonal antibodies used for cell staining and cell sorting are listed below according to their specificity, conjugated fluorochrome or biotin and source. Anti-CD8a (clone 53-6-7) conjugated to allophycocyanine (APC) or conjugated to phycoerythrin (PE), anti-CD11b (clone M/70) conjugated to biotin, GR-1 (clone 8C5) conjugated to biotin, anti-CD45RB (B-220, clone R6B2) conjugated to biotin, TER-119 conjugated to biotin, anti-Thy-1.2 (clone 30-H.12) conjugated to biotin, CD3 (clone 145-2C11) conjugated to APC or PE, ␣␤-TCR (clone H57-597) conjugated to fluorescein isothiocyanate (FITC), ␥␦-TCR conjugated to FITC, were purchased from PharMingen (San Diego, CA, USA). The specificity of these antibodies have been described previously. 16, 17 PE-or FITC-conjugated CD4 antibody was purchased from Caltag Laboratories, South San Francisco, CA, USA. Streptavidin (SA) conjugated to RED-613 and guinea-pig complement were purchased from Gibco/BRL (Grand Island, NY, USA). Polyclonal rabbit anti-mouse brain (RAMB) antibody was a kind gift from Dr Suzanne Ildstad (University of Pittsburgh, PA, USA). Streptavidin (SA)-Dynal ferromagnetic beads were purchased from Dynal Corporation, (New York, NY, USA). For MACS enrichment, CD8 microbeads and the magnetic cell separator instrument (Vario-MACS) were purchased from Miltenyi Biotec (Auburn, CA, USA).
Preparation of bone marrow suspension and immunofluorescent staining
The bone marrow was flushed with sterile medium 199 M199/g (M-199, Gibco, Grand Island, NY, USA) containing 10 g/ml of gentamycin from the femurs of B10 and B10.BR mice using a 22-gauge needle. The marrow was resuspended by repeated aspiration using an 10 ml syringe attached to an 18-gauge needle. For immunofluorescent staining, 2 × 10 6 bone marrow cells were stained with the desired panel of antibodies for multi-parameter FACS analysis as described. 15, 17 For three-color staining, bone marrow cells were stained with APC-conjugated CD8, or PE-conjugated CD8, biotinylated-CD4 followed by SA-RED-613 and ␣␤-TCR FITC and ␥␦-TCR FITC. In some instances, APC-conjugated CD3 antibody was used in combination with TCR and either CD8 or CD4 antibodies. The cells were then washed with cell-staining media (CSM) consisting of Hank's balanced salt solution (HBSS) containing 2.0% fetal bovine serum (FBS), 10 mm HEPES, 1 mm EDTA, and 0.1% BSA and sodium azide was added at 0.02%. Next, the cells were incubated with RED-613 and ␣␤-TCR FITC and ␥␦-TCR FITC for an additional 30 min. Finally, the cells were washed and analyzed using a FACS Vantage flow cytometer (Becton Dickinson, San Jose, CA, USA).
Enrichment of CD8 + cells from murine bone marrow by MACS-microbead selection
Mouse bone marrow cells were enriched for CD8 + population by the MACS-selection procedure. Usually, 1 × 10 8 bone marrow cells were incubated with 200 l of CD8-MACS microbeads, with intermittent gentle agitation to prevent clumping, for 20 min at 4°C. Next, the cells were washed with cold CSM for 5 min at 400 g. The pelleted cells were resuspended in 1.0 ml of CSM. The MACS separator was assembled according to the manufacturer's instructions and the column was rinsed thoroughly with 70% ethanol for sterilization and subsequently washed with CSM. Cells were then applied to the column with a pipette and the flow through was collected. The flow through was reapplied to the column to minimize cell loss and the second flow through fraction was collected as the CD8 Ϫ fraction. The column was washed with three column volumes of CSM which was collected as the wash fraction. The column was removed from the magnet and the selected cells were flushed from the column. This fraction was labeled as the CD8 + fraction. A small aliquot from each of these fractions was analyzed in the FACS Vantage.
Negative selection for T cell enrichment and multiparameter cell sorting
In order to enrich T cells, B10.BR bone marrow cells were depleted of B cells, macrophages, granulocytes, and erythrocytes by bead depletion. Briefly, 5 × 10 8 B10.BR bone marrow cells were stained with a cocktail of biotinylated antibodies comprised of GR-1, CD11b, CD45RB and TER119 for 30 min on ice. The cells were washed twice with CSM and the pellet was resuspended in 7 ml of CSM.
SA-Dynal beads were prepared according to the manufacturer's protocols. Briefly, about 15 × and immediately placed into a Dynal MPC-6 magnet for 10 min. The uncaptured cells remaining in suspension were transferred with a wide-bore transfer pipette into a sterile 15 ml tube. The cells were counted, pelleted at 400 g for 10 min at 4°C, and the pellet was resuspended in 0.6 ml of CSM. To detect any biotinylated antibodies that may have escaped magnetic bead separation, cells were incubated with SA-RED-613 (usually 0.25 g/per 10 6 cells) for 15-20 min on ice. The cells were washed as described above and incubated with the following pre-titered antibodies: CD8-PE, ␣␤-TCR FITC and ␥␦-TCR FITC-conjugated antibodies. Cells were incubated for 20-30 min on ice, washed, and resuspended in CSM at 10 × 10 6 cells/ml. When CD4 and CD8 cells were sorted, the lineage-depleted cells were stained with APC-CD8 and CD4-PE. Cells were analyzed and sorted in the FACS Vantage by setting electronic gates. As controls and to calibrate the flow cytometer, unstained cells as well as cells stained with isotype control antibodies were used to determine autofluorescence and non-specific fluorescence, respectively. For sorting purposes the forward and side scatter gates were used to establish a gated lymphoid population. After the cells were sorted, each population was reanalyzed to determine purity.
T cell depletion of bone marrow
B10 and B10.BR bone marrow cells were T cell-depleted by either RAMB followed by complement treatment or by magnetic bead depletion of Thy-1.2 + cells. 5, 14 For T cell depletion by complement-mediated lysis, cells isolated from B10 and B10.BR femurs were washed and resuspended in M199/G and incubated with rabbit anti-mouse brain serum on ice for 30 min. RAMB-treated cells were washed with M199/G and resuspended in M199/G containing guinea-pig complement (GIBCO/BRL) as described previously. 15 The suspensions were placed at 37°C, for 30 min, washed with M199/G and placed in ice.
Alternatively, cells isolated from B10 and B10.BR femurs were incubated for 30 min on ice with anti-Thy 1.2 biotin (clone 53-2.1; PharMingen), using 50 g/1 × 10 8 cells/ml. Cells were washed and resuspended at 1 × 10 8 /ml. As pre-depletion samples, 1 × 10 6 cells were removed from each cell suspension. The cells were mixed with Dynal M280 Streptavidin beads, prepared as described above, at three beads/cell and placed on a rotator, set at 3-4 r.p.m., at 4°C, for 40 min. Next, the cell/bead suspension was placed in a Dynal MPC-1 magnet for 10 min and the supernatant collected as the Thy 1.2-depleted fraction. The cells were washed and resuspended in CSM. 1 × 10 6 cells were removed from each Thy 1.2-depleted fraction. The pre-and post-depletion samples removed from the suspension were stained with Streptavidin-PerCP (Gibco/BRL), using 0.25 g/1 × 10 6 cells in 100 l reaction volume, incubated on ice for 20 min. The stained cells were washed in CSM and resuspended in approximately 300 l CSM for analysis of Thy1.2 depletion on the FACS Vantage (Becton Dickinson). In some experiments, the pre-and postdepletion samples were stained after SA-PerCP treatment, with anti-CD8-APC, anti-TCR(␣␤) FITC and anti-TCR(␥␦) FITC at 0.5 g/1 × 10 6 cells.
Preparation of chimeras
The preparation of allogeneic bone marrow chimeras has been previously described in detail. 11, 15 Briefly, the B10 and B10.BR bone marrow cells (BMC) were T cell-depleted by either RAMB followed by complement treatment or by magnetic bead depletion of Thy-1.2 + cells. Six-week-old B10 recipient mice were lethally irradiated with a dose of 950 cGy from a Cesium source (SRI-International, Menlo Park, CA, USA). In the control group, animals received 5 × 10 6 TCD B10 BMC and 5 × 10 6 TCD B10.BR BMC to obtain the baseline value for mixed chimeras. In some experiments, allogeneic B10.BR TCD-BMC numbers were increased to 15 × 10 6 while keeping the syngeneic B10 BMC number at 5 × 10 6 . To determine the efficacy of MACS-enriched CD8
+ cells in promoting engraftment, lethally irradiated mice received 5 × 10 6 TCD B10 BMC and 5 × 10 6 TCD B10.BR BMC plus 100 000 CD8-enriched cells. For sorter purified cells, usually 50 000 cells were used along with the TCD syngeneic and allogeneic bone marrow cells. Another group of irradiated control mice received M-199 medium only.
Peripheral blood cell staining of chimeras
In order to determine the presence of allogeneic and syngeneic cells in the irradiated bone marrow chimeras, PBL samples from recipient mice were analyzed 4-6 weeks after treatment. Heparinized peripheral blood samples were collected into plastic tubes and diluted 1:3 with phosphatebuffered saline (PBS, pH 7.4). After thorough mixing, the suspension was layered over 1. 
Results
Bone marrow cells were stained with antibodies for the T cell surface markers CD4, CD8, CD3 and TCR-␣␤ and TCR-␥␦ antigens by multiparameter FACS analysis. Data obtained from one such experiment, presented in Figure 1 Since the CD8 + cells are of critical importance to this study, profiles of CD8 vs TCR and CD8 vs CD3 for bone marrow lymphoid cells are shown in panels d and e (Figure 1 ), respectively. In these analyses, we did not detect a defined population of CD8 + cells that + cells in these plots which are negative for TCR and CD3, most express lower levels of CD8 in comparison to the TCR + CD3 + population. Therefore, the majority of the CD8-expressing cells in mouse bone marrow appears to be a mature subset of T cells.
Immunomagnetic selection was used to enrich the bone marrow CD8 cell population and to determine its ability to facilitate allogeneic stem cell engraftment as described in Materials and methods. Figure 2 + cells was found to be negative for the CD3 antigen which may account for a NK cell population. When only those cells falling within the lymphoid gate are taken into consideration, more than 80% of MACS-enriched cells were found to be CD8 + . For cell sorter purification of CD8 + cells, bone marrow cells were first depleted of other mature cells by negative selection through magnetic bead depletion as described in Materials and methods. After each sort, a sample of the collected CD8
+ population was reanalyzed to assess purity. A representative plot of CD8 reanalysis is presented in Figure 3 (panel b) . For comparison, unmanipulated cell staining data with respect to CD8 vs TCR (␣␤ and ␥␦) is also presented (panel a). The data show that more than 97% of the sorted cells are positive for both the surface markers and represent a mature population of T cells. The relative maturational stage of these CD8
+ cells with respect to the CD8 cell subsets found in the thymus, peripheral blood or in the lymph nodes is not clear at this time.
FACS-purified CD8 + cells and MACS-enriched CD8 + populations were compared for their ability to enhance the engraftment of TCD bone marrow in lethally irradiated allogeneic recipients. In each experiment, 5 × 10 4 FACSsorted CD8
+ or 1 × 10 5 MACS-enriched CD8 + cells from the bone marrow of B10.BR mice were administered along with 5 × 10 6 TCD B10 and 5 × 10 6 TCD B10.BR bone marrow cells. This provided recipients with comparable doses of CD8
+ lymphoid cells prepared either by flow cytometry or by immunomagnetic bead selection procedures. Negative controls for the effect of CD8 + cells added to the bone marrow inocula included mice receiving 5 × 10 4 FACS-purified CD4 + cells or 1 × 10 5 CD8-depleted bone marrow cells as indicated. The CD8-depleted bone marrow contained Ͻ1% of CD8
+ cells, as determined by post-depletion FACS analysis. Chimerism in PBL of surviving mice was assessed at 4-6 weeks post-bone marrow transplantation. Data obtained from three such experiments are shown in Table  1 . When mice received equivalent numbers of TCD syngeneic and allogeneic bone marrow cells, engraftment was predominantly syngeneic. The low level of chimerism achieved in these recipients is consistent with the results of other studies published previously. 11, 12 The addition of FACS-purified CD8 + cells enhanced allogeneic engraftment and subsequent chimerism in the PBL more than four-fold.
In the other two experiments, we directly compared the ability of MACS-enriched CD8
+ cells with that of the FACS-purified CD8 + cells (Table 1) . In both experiments, the CD8 + cell population gave significantly higher allogeneic engraftment compared to their respective control groups. More importantly, none of the recipient mice in these groups presented symptoms of graft-versus-host disease.
It should be noted that the level of allogeneic engraftment in recipients receiving either CD4
+ BM cells or CD8-depleted BM cells is significantly greater in Expt 3 than in Expt 2 ( Table 1) . We attribute this difference to the method of T cell depletion utilized in the preparation of the syngeneic and allogeneic marrow. In Expt 2, TCD was performed using RAMB plus complement whereas in Expt 3 specific depletion by immunomagnetic selection with Thy1.2 mAb was employed. It is possible that the latter technique is less effective than the RAMB plus complement treatment in removing T cells from the marrow. Alternatively, RAMB is a polyclonal antiserum known to have anti-Thy1.2 specificity but its effects on other cell populations present in the marrow is largely unknown. In addition, a certain amount of non-specific complementmediated lysis of cells is also observed which may influence the viability of the cells used in these BM transplants. Nevertheless, animals receiving CD8-supplemented TCD BM showed approximately two-fold greater allogeneic engraftment compared with their respective controls.
Discussion
The function of T cells in bone marrow engraftment has been under investigation for some time using different animal models. Murphy et al 18 have shown that absence of T cells in mouse bone marrow grafts leads to an increased susceptibility to rejection of the graft by host T cells and NK cells. In addition, results obtained from different laboratories have suggested the importance of CD8 + cells in facilitating engraftment across histocompatability disparities. [13] [14] [15] Data presented in this report confirm and extend these studies in demonstrating a simple method of enriching the facilitating activity present in the marrow for use in in vivo functional assays. It should be mentioned that the + subpopulation present in the enriched BM fractions and suggests a titratable effect in these cells.
Kaufman et al 15 have described a CD8 + CD3 + TCR Ϫ facilitating cell population in bone marrow which enhanced purified stem cell engraftment in an allogeneic murine model. Moreover, they have also shown that transfer of purified CD8
+ facilitating cells along with MHC-matched fetal liver stem cells into irradiated mice resulted in sustained engraftment with multilineage cell production. 19 In our experiments, most of the CD8 + FACS-purified cells, which facilitated allogeneic bone marrow engraftment, when phenotypically characterized appear to express the TCR antigens. It may be possible that a small number of CD8 + CD3
+ TCR Ϫ facilitating cells were present in our purified CD8 cell fraction. However, in their publication, Kaufman et al 15 have demonstrated that at least 30 000 CD8 + cells were needed to observe moderate levels of chimerism in recipient animals. From the data presented in Figure 3 , it appears that the cell sorter-purified Lin Ϫ CD8 + cells, at best, contained 1000 CD8
+ TCR -cells. Therefore, it seems reasonable to conclude that the facilitating activity of the bone marrow CD8
+ cells resides predominantly within the TCR + population although some activity may be present in the TCR Ϫ subset as well. Recently, Gandy and Weissman 20 have presented data indicating that both TCR + and TCR Ϫ subsets of bone marrow cells are capable of enhancing stem cell engraftment, an observation which corroborates with our results. It may be possible that these two subsets of CD8 + cells are constantly in transition in bone marrow. For this reason, further phenotypic characterization is needed using other T cell differentiation antigens to better segregate these two cell types. We believe that the CD8 + TCR + cells from bone marrow are involved in enhancing allogeneic, T cell-depleted, bone marrow transplantation, in much the same way as the cell population described in the thymus 13 and in the lymph node.
14 In summary, we have shown in this report that immunomagnetic enrichment of CD8 + cells from mouse bone marrow is quite comparable with cell sorter purified CD8
+ cells in terms of facilitating allogeneic T cell-depleted bone marrow transplantation. Other investigators have examined immunomagnetic separation as an efficient way of recovering CD34
+ precursor cells for human transplantation. 21, 22 Our results suggest the possibility of extending this application to isolate engraftment-facilitating T cells for allogeneic stem cell transplantation protocols. 
